PD34: Stone Disease: Epidemiology & Evaluation II

Podium Session Moderator(s)

• 

  Brian Eisner, MD

  Associate Professor of Urology
  Massachusetts General Hospital
• MO

  Michael Ordon

  MD, MSc, FRCSC
  University of Toronto
• CS

  Charles Scales, Jr., MD, FACS, MS (he/him/his)

  Duke University School of Medicine

Presentations:

• 1:00 PM – 1:10 PM CST

  PD34-01: Development of a Patient-Centered Research Agenda for Kidney Stone Disease: Elicitation and Refinement of Research Themes
  

  Podium Presenter: Jonathan S. Ellison, MD (he/him/his)
• 1:10 PM – 1:20 PM CST

  PD34-02: Diversity, Equity, and Inclusion in Urolithiasis Clinical Trials: Representative Enrollment by Race, Ethnicity and Sex
  

  Podium Presenter: Amy Reed, MD
• 1:20 PM – 1:30 PM CST

  PD34-03: Pre-operative Central Sensitization and Hypersensitivity to Pain is Associated with Ureteral Stent Pain: Findings from the Urinary Stone Disease Research Network (USDRN)
  

  Podium Presenter: Henry Henry Lai, MD – Washington University School of Medicine
• 1:30 PM – 1:40 PM CST

  PD34-04: Predictive Models for Severe Pain and Urinary Symptoms after Ureteroscopy with Ureteral Stent Placement from the USDRN STENTS study
  

  Podium Presenter: Gregory E. Tasian, MD – Children's Hospital of Philadelphia
• 1:40 PM – 1:50 PM CST

  PD34-05: A Novel Machine-Learning Algorithm to Predict Stone Recurrence with 24-hour urine data
  

  Podium Presenter: Kevin Shee, MD, PHD – UCSF Urology
• 1:50 PM – 2:00 PM CST

  PD34-06: Machine Learning Prediction of Symptomatic Kidney Stone Recurrence Using 24-Hour Urine Data and Electronic Health Record Derived Features
  

  Podium Presenter: Patrick Waldron Doyle, BS
• 2:00 PM – 2:10 PM CST

  PD34-07: Can Convolutional Neural Network be applied to the prediction of urinary stone composition in single-use flexible ureteroscopic images?
  

  Podium Presenter: Kyung Tak Oh
• 2:10 PM – 2:20 PM CST

  PD34-08: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors Are Associated With a Decreased Risk of Urolithiasis Compared to Other Antihyperglycemics Among Stone-Naive Diabetics
  

  Podium Presenter: Ridwan I. Alam, MD, MPH
• 2:20 PM – 2:30 PM CST

  PD34-09: The Association between Organophosphate Insecticides and Kidney Stone Formation among U.S. Adults
  

  Podium Presenter: Frank Glover, III, PhD
• 2:30 PM – 2:40 PM CST

  PD34-10: Impact of Sepsis on Admissions, Re Admissions and Mortality Following Ureteroscopy
  

  Podium Presenter: Naeem Bhojani, MD – University of Montreal
• 2:40 PM – 2:50 PM CST

  PD34-11: One Week Preoperative Oral Antibiotics for Percutaneous Nephrolithotomy Reduce Risk of Infection: a Systematic Review and Meta-Analysis
  

  Podium Presenter: Thalita Bento Talizin, MD,MSC
• 2:50 PM – 3:00 PM CST

  PD34-12: The role of Microscopic Hematuria in Symptomatic Children with Suspected Urinary Stones
  

  Podium Presenter: Yossi Ventura, MD,BA